Primary	O
pituitary	B:C0032005
diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
with	O
somatotroph	O
hyperplasia	I:C0342369
and	O
acromegaly	O
:	O
case	O
report	I:C0085973
.	O

Primary	O
pituitary	O
diffuse	B:C0079744
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
with	O
somatotroph	O
hyperplasia	I:C0342369
and	O
acromegaly	O
:	O
case	O
report	I:C0085973
.	O

Primary	O
pituitary	O
diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
with	O
somatotroph	B:C0342369
hyperplasia	I:C0342369
and	O
acromegaly	O
:	O
case	O
report	I:C0085973
.	O

Primary	O
pituitary	O
diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
with	O
somatotroph	O
hyperplasia	I:C0342369
and	O
acromegaly	B:C0001206
:	O
case	O
report	I:C0085973
.	O

Primary	O
pituitary	O
diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
with	O
somatotroph	O
hyperplasia	I:C0342369
and	O
acromegaly	O
:	O
case	B:C0085973
report	I:C0085973
.	O

Diffuse	B:C0079744
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
(	O
Diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
)	O
is	O
the	O
most	O
common	O
type	O
of	O
non-Hodgkin	O
lymphoma	I:C0024305
and	O
comprises	O
approximately	O
30	O
%	O
of	O
all	O
lymphomas	O
.	O

Diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
(	O
Diffuse	B:C0079744
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
)	O
is	O
the	O
most	O
common	O
type	O
of	O
non-Hodgkin	O
lymphoma	I:C0024305
and	O
comprises	O
approximately	O
30	O
%	O
of	O
all	O
lymphomas	O
.	O

Diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
(	O
Diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
)	O
is	O
the	O
most	O
common	O
type	O
of	O
non-Hodgkin	B:C0024305
lymphoma	I:C0024305
and	O
comprises	O
approximately	O
30	O
%	O
of	O
all	O
lymphomas	O
.	O

Diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
(	O
Diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
)	O
is	O
the	O
most	O
common	O
type	O
of	O
non-Hodgkin	O
lymphoma	I:C0024305
and	O
comprises	O
approximately	O
30	O
%	O
of	O
all	O
lymphomas	B:C0024299
.	O

Patients	O
typically	O
present	B:C0150312
with	O
a	O
nonpainful	O
mass	O
in	O
the	O
neck	O
,	O
groin	O
,	O
or	O
abdomen	O
associated	O
with	O
constitutional	O
symptoms	I:C0009812
.	O

Patients	O
typically	O
present	O
with	O
a	O
nonpainful	O
mass	B:C0577559
in	O
the	O
neck	O
,	O
groin	O
,	O
or	O
abdomen	O
associated	O
with	O
constitutional	O
symptoms	I:C0009812
.	O

Patients	O
typically	O
present	O
with	O
a	O
nonpainful	O
mass	O
in	O
the	O
neck	B:C0027530
,	O
groin	O
,	O
or	O
abdomen	O
associated	O
with	O
constitutional	O
symptoms	I:C0009812
.	O

Patients	O
typically	O
present	O
with	O
a	O
nonpainful	O
mass	O
in	O
the	O
neck	O
,	O
groin	B:C0018246
,	O
or	O
abdomen	O
associated	O
with	O
constitutional	O
symptoms	I:C0009812
.	O

Patients	O
typically	O
present	O
with	O
a	O
nonpainful	O
mass	O
in	O
the	O
neck	O
,	O
groin	O
,	O
or	O
abdomen	B:C0000726
associated	O
with	O
constitutional	O
symptoms	I:C0009812
.	O

Patients	O
typically	O
present	O
with	O
a	O
nonpainful	O
mass	O
in	O
the	O
neck	O
,	O
groin	O
,	O
or	O
abdomen	O
associated	O
with	O
constitutional	B:C0009812
symptoms	I:C0009812
.	O

In	O
this	O
report	B:C0684224
,	O
however	O
,	O
the	O
authors	O
describe	O
a	O
rare	O
case	O
of	O
a	O
61	O
-	O
year	O
-	O
old	O
woman	O
with	O
hyperprolactinemia	O
,	O
hypothyroidism	O
,	O
and	O
acromegaly	O
(	O
elevation	O
of	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
[	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
]	O
)	O
with	O
elevated	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
(	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
)	O
in	O
whom	O
an	O
MRI	O
demonstrated	O
diffuse	O
enlargement	I:C0877018
of	I:C0877018
the	I:C0877018
pituitary	I:C0877018
gland	I:C0877018
.	O

In	O
this	O
report	O
,	O
however	O
,	O
the	O
authors	B:C3812881
describe	O
a	O
rare	O
case	O
of	O
a	O
61	O
-	O
year	O
-	O
old	O
woman	O
with	O
hyperprolactinemia	O
,	O
hypothyroidism	O
,	O
and	O
acromegaly	O
(	O
elevation	O
of	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
[	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
]	O
)	O
with	O
elevated	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
(	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
)	O
in	O
whom	O
an	O
MRI	O
demonstrated	O
diffuse	O
enlargement	I:C0877018
of	I:C0877018
the	I:C0877018
pituitary	I:C0877018
gland	I:C0877018
.	O

In	O
this	O
report	O
,	O
however	O
,	O
the	O
authors	O
describe	O
a	O
rare	O
case	O
of	O
a	O
61	O
-	O
year	O
-	O
old	O
woman	B:C0043210
with	O
hyperprolactinemia	O
,	O
hypothyroidism	O
,	O
and	O
acromegaly	O
(	O
elevation	O
of	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
[	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
]	O
)	O
with	O
elevated	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
(	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
)	O
in	O
whom	O
an	O
MRI	O
demonstrated	O
diffuse	O
enlargement	I:C0877018
of	I:C0877018
the	I:C0877018
pituitary	I:C0877018
gland	I:C0877018
.	O

In	O
this	O
report	O
,	O
however	O
,	O
the	O
authors	O
describe	O
a	O
rare	O
case	O
of	O
a	O
61	O
-	O
year	O
-	O
old	O
woman	O
with	O
hyperprolactinemia	B:C0020514
,	O
hypothyroidism	O
,	O
and	O
acromegaly	O
(	O
elevation	O
of	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
[	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
]	O
)	O
with	O
elevated	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
(	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
)	O
in	O
whom	O
an	O
MRI	O
demonstrated	O
diffuse	O
enlargement	I:C0877018
of	I:C0877018
the	I:C0877018
pituitary	I:C0877018
gland	I:C0877018
.	O

In	O
this	O
report	O
,	O
however	O
,	O
the	O
authors	O
describe	O
a	O
rare	O
case	O
of	O
a	O
61	O
-	O
year	O
-	O
old	O
woman	O
with	O
hyperprolactinemia	O
,	O
hypothyroidism	B:C0020676
,	O
and	O
acromegaly	O
(	O
elevation	O
of	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
[	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
]	O
)	O
with	O
elevated	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
(	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
)	O
in	O
whom	O
an	O
MRI	O
demonstrated	O
diffuse	O
enlargement	I:C0877018
of	I:C0877018
the	I:C0877018
pituitary	I:C0877018
gland	I:C0877018
.	O

In	O
this	O
report	O
,	O
however	O
,	O
the	O
authors	O
describe	O
a	O
rare	O
case	O
of	O
a	O
61	O
-	O
year	O
-	O
old	O
woman	O
with	O
hyperprolactinemia	O
,	O
hypothyroidism	O
,	O
and	O
acromegaly	B:C0001206
(	O
elevation	O
of	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
[	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
]	O
)	O
with	O
elevated	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
(	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
)	O
in	O
whom	O
an	O
MRI	O
demonstrated	O
diffuse	O
enlargement	I:C0877018
of	I:C0877018
the	I:C0877018
pituitary	I:C0877018
gland	I:C0877018
.	O

In	O
this	O
report	O
,	O
however	O
,	O
the	O
authors	O
describe	O
a	O
rare	O
case	O
of	O
a	O
61	O
-	O
year	O
-	O
old	O
woman	O
with	O
hyperprolactinemia	O
,	O
hypothyroidism	O
,	O
and	O
acromegaly	O
(	O
elevation	O
of	O
insulin	B:C0021665
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
[	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
]	O
)	O
with	O
elevated	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
(	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
)	O
in	O
whom	O
an	O
MRI	O
demonstrated	O
diffuse	O
enlargement	I:C0877018
of	I:C0877018
the	I:C0877018
pituitary	I:C0877018
gland	I:C0877018
.	O

In	O
this	O
report	O
,	O
however	O
,	O
the	O
authors	O
describe	O
a	O
rare	O
case	O
of	O
a	O
61	O
-	O
year	O
-	O
old	O
woman	O
with	O
hyperprolactinemia	O
,	O
hypothyroidism	O
,	O
and	O
acromegaly	O
(	O
elevation	O
of	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
[	O
insulin	B:C0021665
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
]	O
)	O
with	O
elevated	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
(	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
)	O
in	O
whom	O
an	O
MRI	O
demonstrated	O
diffuse	O
enlargement	I:C0877018
of	I:C0877018
the	I:C0877018
pituitary	I:C0877018
gland	I:C0877018
.	O

In	O
this	O
report	O
,	O
however	O
,	O
the	O
authors	O
describe	O
a	O
rare	O
case	O
of	O
a	O
61	O
-	O
year	O
-	O
old	O
woman	O
with	O
hyperprolactinemia	O
,	O
hypothyroidism	O
,	O
and	O
acromegaly	O
(	O
elevation	O
of	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
[	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
]	O
)	O
with	O
elevated	O
growth	B:C0037668
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
(	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
)	O
in	O
whom	O
an	O
MRI	O
demonstrated	O
diffuse	O
enlargement	I:C0877018
of	I:C0877018
the	I:C0877018
pituitary	I:C0877018
gland	I:C0877018
.	O

In	O
this	O
report	O
,	O
however	O
,	O
the	O
authors	O
describe	O
a	O
rare	O
case	O
of	O
a	O
61	O
-	O
year	O
-	O
old	O
woman	O
with	O
hyperprolactinemia	O
,	O
hypothyroidism	O
,	O
and	O
acromegaly	O
(	O
elevation	O
of	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
[	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
]	O
)	O
with	O
elevated	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
(	O
growth	B:C0037668
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
)	O
in	O
whom	O
an	O
MRI	O
demonstrated	O
diffuse	O
enlargement	I:C0877018
of	I:C0877018
the	I:C0877018
pituitary	I:C0877018
gland	I:C0877018
.	O

In	O
this	O
report	O
,	O
however	O
,	O
the	O
authors	O
describe	O
a	O
rare	O
case	O
of	O
a	O
61	O
-	O
year	O
-	O
old	O
woman	O
with	O
hyperprolactinemia	O
,	O
hypothyroidism	O
,	O
and	O
acromegaly	O
(	O
elevation	O
of	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
[	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
]	O
)	O
with	O
elevated	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
(	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
)	O
in	O
whom	O
an	O
MRI	B:C0024485
demonstrated	O
diffuse	O
enlargement	I:C0877018
of	I:C0877018
the	I:C0877018
pituitary	I:C0877018
gland	I:C0877018
.	O

In	O
this	O
report	O
,	O
however	O
,	O
the	O
authors	O
describe	O
a	O
rare	O
case	O
of	O
a	O
61	O
-	O
year	O
-	O
old	O
woman	O
with	O
hyperprolactinemia	O
,	O
hypothyroidism	O
,	O
and	O
acromegaly	O
(	O
elevation	O
of	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
[	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
]	O
)	O
with	O
elevated	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
(	O
growth	O
hormone	I:C0037668
-	I:C0037668
releasing	I:C0037668
hormone	I:C0037668
)	O
in	O
whom	O
an	O
MRI	O
demonstrated	O
diffuse	B:C0877018
enlargement	I:C0877018
of	I:C0877018
the	I:C0877018
pituitary	I:C0877018
gland	I:C0877018
.	O

Despite	O
medical	B:C0418981
treatment	I:C0418981
,	O
the	O
patient	O
had	O
persistent	O
elevation	O
of	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
.	O

Despite	O
medical	O
treatment	I:C0418981
,	O
the	O
patient	O
had	O
persistent	O
elevation	O
of	O
insulin	B:C0021665
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
.	O

She	O
underwent	O
a	O
transsphenoidal	B:C0176118
biopsy	I:C0176118
,	O
which	O
yielded	O
a	O
diagnosis	O
of	O
Diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
with	O
an	O
activated	O
B	O
-	I:C0004561
cell	I:C0004561
immunophenotype	O
with	O
somatotroph	O
hyperplasia	I:C0342369
.	O

She	O
underwent	O
a	O
transsphenoidal	O
biopsy	I:C0176118
,	O
which	O
yielded	O
a	O
diagnosis	B:C0011900
of	O
Diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
with	O
an	O
activated	O
B	O
-	I:C0004561
cell	I:C0004561
immunophenotype	O
with	O
somatotroph	O
hyperplasia	I:C0342369
.	O

She	O
underwent	O
a	O
transsphenoidal	O
biopsy	I:C0176118
,	O
which	O
yielded	O
a	O
diagnosis	O
of	O
Diffuse	B:C0079744
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
with	O
an	O
activated	O
B	O
-	I:C0004561
cell	I:C0004561
immunophenotype	O
with	O
somatotroph	O
hyperplasia	I:C0342369
.	O

She	O
underwent	O
a	O
transsphenoidal	O
biopsy	I:C0176118
,	O
which	O
yielded	O
a	O
diagnosis	O
of	O
Diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
with	O
an	O
activated	O
B	B:C0004561
-	I:C0004561
cell	I:C0004561
immunophenotype	O
with	O
somatotroph	O
hyperplasia	I:C0342369
.	O

She	O
underwent	O
a	O
transsphenoidal	O
biopsy	I:C0176118
,	O
which	O
yielded	O
a	O
diagnosis	O
of	O
Diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
with	O
an	O
activated	O
B	O
-	I:C0004561
cell	I:C0004561
immunophenotype	B:C0079611
with	O
somatotroph	O
hyperplasia	I:C0342369
.	O

She	O
underwent	O
a	O
transsphenoidal	O
biopsy	I:C0176118
,	O
which	O
yielded	O
a	O
diagnosis	O
of	O
Diffuse	O
large	I:C0079744
B	I:C0079744
-	I:C0079744
cell	I:C0079744
lymphoma	I:C0079744
with	O
an	O
activated	O
B	O
-	I:C0004561
cell	I:C0004561
immunophenotype	O
with	O
somatotroph	B:C0342369
hyperplasia	I:C0342369
.	O

After	O
stereo-	B:C3896609
tactic	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
in	O
combination	O
with	O
chemotherapy	O
,	O
she	O
is	O
currently	O
in	O
remission	O
from	O
her	O
lymphoma	O
and	O
has	O
normalized	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
levels	O
without	O
medical	O
therapy	I:C0418981
,	O
8	O
months	O
after	O
her	O
histopathological	O
diagnosis	O
.	O

After	O
stereo-	O
tactic	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
in	O
combination	O
with	O
chemotherapy	B:C3665472
,	O
she	O
is	O
currently	O
in	O
remission	O
from	O
her	O
lymphoma	O
and	O
has	O
normalized	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
levels	O
without	O
medical	O
therapy	I:C0418981
,	O
8	O
months	O
after	O
her	O
histopathological	O
diagnosis	O
.	O

After	O
stereo-	O
tactic	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
in	O
combination	O
with	O
chemotherapy	O
,	O
she	O
is	O
currently	O
in	O
remission	B:C0687702
from	O
her	O
lymphoma	O
and	O
has	O
normalized	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
levels	O
without	O
medical	O
therapy	I:C0418981
,	O
8	O
months	O
after	O
her	O
histopathological	O
diagnosis	O
.	O

After	O
stereo-	O
tactic	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
in	O
combination	O
with	O
chemotherapy	O
,	O
she	O
is	O
currently	O
in	O
remission	O
from	O
her	O
lymphoma	B:C0024299
and	O
has	O
normalized	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
levels	O
without	O
medical	O
therapy	I:C0418981
,	O
8	O
months	O
after	O
her	O
histopathological	O
diagnosis	O
.	O

After	O
stereo-	O
tactic	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
in	O
combination	O
with	O
chemotherapy	O
,	O
she	O
is	O
currently	O
in	O
remission	O
from	O
her	O
lymphoma	O
and	O
has	O
normalized	B:C1882115
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
levels	O
without	O
medical	O
therapy	I:C0418981
,	O
8	O
months	O
after	O
her	O
histopathological	O
diagnosis	O
.	O

After	O
stereo-	O
tactic	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
in	O
combination	O
with	O
chemotherapy	O
,	O
she	O
is	O
currently	O
in	O
remission	O
from	O
her	O
lymphoma	O
and	O
has	O
normalized	O
insulin	B:C0021665
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
levels	O
without	O
medical	O
therapy	I:C0418981
,	O
8	O
months	O
after	O
her	O
histopathological	O
diagnosis	O
.	O

After	O
stereo-	O
tactic	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
in	O
combination	O
with	O
chemotherapy	O
,	O
she	O
is	O
currently	O
in	O
remission	O
from	O
her	O
lymphoma	O
and	O
has	O
normalized	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
levels	O
without	O
medical	B:C0418981
therapy	I:C0418981
,	O
8	O
months	O
after	O
her	O
histopathological	O
diagnosis	O
.	O

After	O
stereo-	O
tactic	I:C3896609
radiation	I:C3896609
therapy	I:C3896609
in	O
combination	O
with	O
chemotherapy	O
,	O
she	O
is	O
currently	O
in	O
remission	O
from	O
her	O
lymphoma	O
and	O
has	O
normalized	O
insulin	O
-	I:C0021665
like	I:C0021665
growth	I:C0021665
factor	I:C0021665
-	I:C0021665
1	I:C0021665
levels	O
without	O
medical	O
therapy	I:C0418981
,	O
8	O
months	O
after	O
her	O
histopathological	O
diagnosis	B:C0011900
.	O

This	O
is	O
the	O
only	O
reported	B:C0684224
case	O
of	O
its	O
kind	O
and	O
displays	O
the	O
importance	O
of	O
a	O
broad	O
differential	O
diagnosis	I:C0011906
,	O
multidisciplinary	O
evaluation	I:C0729737
,	O
and	O
critical	O
intraoperative	O
decision	O
-	I:C0011109
making	I:C0011109
when	O
treating	O
atypical	O
sellar	O
lesions	O
.	O

This	O
is	O
the	O
only	O
reported	O
case	O
of	O
its	O
kind	O
and	O
displays	O
the	O
importance	O
of	O
a	O
broad	O
differential	B:C0011906
diagnosis	I:C0011906
,	O
multidisciplinary	O
evaluation	I:C0729737
,	O
and	O
critical	O
intraoperative	O
decision	O
-	I:C0011109
making	I:C0011109
when	O
treating	O
atypical	O
sellar	O
lesions	O
.	O

This	O
is	O
the	O
only	O
reported	O
case	O
of	O
its	O
kind	O
and	O
displays	O
the	O
importance	O
of	O
a	O
broad	O
differential	O
diagnosis	I:C0011906
,	O
multidisciplinary	B:C0729737
evaluation	I:C0729737
,	O
and	O
critical	O
intraoperative	O
decision	O
-	I:C0011109
making	I:C0011109
when	O
treating	O
atypical	O
sellar	O
lesions	O
.	O

This	O
is	O
the	O
only	O
reported	O
case	O
of	O
its	O
kind	O
and	O
displays	O
the	O
importance	O
of	O
a	O
broad	O
differential	O
diagnosis	I:C0011906
,	O
multidisciplinary	O
evaluation	I:C0729737
,	O
and	O
critical	O
intraoperative	O
decision	B:C0011109
-	I:C0011109
making	I:C0011109
when	O
treating	O
atypical	O
sellar	O
lesions	O
.	O

This	O
is	O
the	O
only	O
reported	O
case	O
of	O
its	O
kind	O
and	O
displays	O
the	O
importance	O
of	O
a	O
broad	O
differential	O
diagnosis	I:C0011906
,	O
multidisciplinary	O
evaluation	I:C0729737
,	O
and	O
critical	O
intraoperative	O
decision	O
-	I:C0011109
making	I:C0011109
when	O
treating	O
atypical	O
sellar	B:C0036609
lesions	O
.	O

This	O
is	O
the	O
only	O
reported	O
case	O
of	O
its	O
kind	O
and	O
displays	O
the	O
importance	O
of	O
a	O
broad	O
differential	O
diagnosis	I:C0011906
,	O
multidisciplinary	O
evaluation	I:C0729737
,	O
and	O
critical	O
intraoperative	O
decision	O
-	I:C0011109
making	I:C0011109
when	O
treating	O
atypical	O
sellar	O
lesions	B:C0221198
.	O

